Trial Profile
Optimization of Cardiac Iodine-123 Meta-iodobenzylguanidine (123I-mIBG) SPECT Imaging
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2017
Price :
$35
*
At a glance
- Drugs Iobenguane (Primary)
- Indications Coronary artery disease; Heart failure
- Focus Diagnostic use
- 19 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record
- 03 Feb 2014 New trial record